Open Pharma

Why open access and plain language matter for students Traditional publishing practices are stifling global academic potential. Dependency on institutional subscriptions for access to academic literature and prolific use of ‘science speak’ hinders student...

Students 🤝 Open science

Paywalls and science speak are holding students back. But they don’t have to wait for change – they can drive it!

Learn how in our latest opinion article: www.openpharma.blog/blog/guest-p...

Sign up to the Open Pharma newsletter: openpharma.blog/#sign-up-to-our-newsletter

Weekly digest: social media, NISO Plus and OA influence on policy This week, we listen to Amanda Solis and Leslie Rotz as they explain how to harness social media for medical research communication. We share a call for proposals for the 2026 NISO Plus conference and...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess @ismpp.bsky.social @nisoinfo.bsky.social @who.int #ClinicalTrials #MedicalResearch

www.openpharma.blog/blog/news/we...

Weekly digest: a Peer Review Week celebration! This week, we’re reflecting on Peer Review Week, which took place from 15 to 19 September and centred around the theme Rethinking peer review in the AI era. We begin by reading about new approaches to...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #PeerReview #PeerReviewWeek #ResearchIntegrity #MedicalPublishing #ScholarlyPublishing

www.openpharma.blog/blog/news/we...

📢 Calling all medical publications professionals 📢

We need your insights! Share your experiences and help us understand the impact of content reuse permissions, restrictions and costs on the dissemination of medical research:
forms.office.com/e/tRUgRZN9kS

Weekly digest: NISO OABP, effective plain language summaries and PLS for APAC This week, we encourage readers to comment on draft OABP recommendations from NISO and complete a survey exploring how to make PLS clearer and more accessible. We also read guidance on how to make PLS accessible in APAC, and we consider when and how to retract an article. We review insights on transparent peer review based on experiences at the European Journal of Higher Education and ask if pharma is ready to rethink implementation for patient centricity. Finally, we listen to the latest MAPS Elevate podcast, which explores how to improve your journal selection process.

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #PlainLanguageSummaries #APAC #Retractions #PeerReview

Weekly digest: suspicious journals, publication extenders and gold-standard science This week, we read about an AI screening tool developed to identify suspicious publishing practices, review evidence on the effectiveness of publication extenders, and examine concerns around the pote...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #AI #Accessibility #ResearchIntegrity #DataSharing

Science on social media: the double-edged sword of public engagement Social media is a powerful tool for science communication, allowing information to be shared at the speed of a swipe. Researchers, funders and communicators can use platforms such as Bluesky, Instagra...

🧠 Swipe wisely: how to share science responsibly on social media

In her new piece, our intern Ellen explores how researchers, communicators and pharma companies can use social media to build trust in science without falling into the trap of misinformation.

www.openpharma.blog/blog/guest-p...

Bayer becomes a Supporter of Open Pharma Open Pharma and Bayer are proud to announce that Bayer has become the latest Supporter of Open Pharma! Open Pharma aims to drive positive change in the communication of research funded by the pharmace...

🎉 Bayer becomes the newest Supporter of Open Pharma!
Read the full press release on our blog 👉 www.openpharma.blog/blog/news/ba...

#OpenPharma #OpenScience #Welcome #Pharma

Weekly digest: open science knowledge graphs, accessibility and coercive citations This week, we read about the OpenAIRE Graph and the steps we can take to make research and healthcare information more accessible to all. We highlight proposed solutions to improve the peer review pro...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #AI #PeerReview #Plagiarism #OpenAIREGraph #ISMPP

Weekly digest: genAI applications, data sharing and open access This week, we explore how to collaborate effectively while using genAI, how genAI can enhance data sharing practices, and how the NIH is approaching its newly announced top priorities and funding revi...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #genAI #DataSharing #ResearchIntegrity #AI

www.openpharma.blog/blog/news/we...

Weekly digest: article extenders, positive peer reviews and open repositories This week, we explore the impact of article extenders on the readership of PLSPs and CTPs, and we review a critique of Nature’s decision to only publish peer review reports for accepted papers. We als...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #PeerReview #ResearchIntegrity #AI

Weekly digest: rewarding peer review, gaming of science and paying patient authors This week, we read about improving incentives for peer reviewers, the author–editor networks that are used to publish fraudulent research and the gaming of the scientific system through strategic mani...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#PeerReview #ScientificPublishing #PatientAuthors #ResponsibleResearch

Weekly digest: AI-assisted gene set analysis, null results and ORCID integration This week, we learn about NIH’s AI breakthrough in gene set analysis and highlight the importance of null results in the advancement of scientific discovery. We explore ORCID’s role in the evolving re...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #AI #MedicalPublishing #NullResults

www.openpharma.blog/blog/news/we...

Your new ISMPP committee members: Sophie Nobes, Digital Engagement and Visual Communications; Joanna Donnelly, Publication Ethics and Standards

👋 Say hello to your new @ismpp.bsky.social committee members

Weekly digest: the easiness effect, copyright with AI and an AI jury This week, we explore how shortform science videos might be compromising our critical thinking. We read about how copyright regulations are changing with AI, and whether an AI jury could help improve ...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#copyright #AI

www.openpharma.blog/blog/news/we...

The PLS Finder: making plain language summaries more discoverable and accessible for everyone A group of publishers, in collaboration with The Synergist, are working together to create The PLS Finder – a comprehensive aggregator of abstract style plain language summaries (PLS) and standalone p...

🔍 Can’t find PLS and PLSPs on PubMed? You’re not alone.

Plain language content is hard to find, but that’s about to change.

🔗Learn more: www.openpharma.blog/blog/guest-p...

#PlainLanguage #HealthLiteracy #OpenScience #PatientEngagement #PLS #MedicalPublishing #ScienceCommunication #ThePLSFinder

Weekly digest: reimagining ePI, AI-driven safeguards and open science indicators This week, we reimagine ePI to transform the way we access and understand medical information and we read about Frontiers’ use of AI tools to check publication integrity. We also consider the importan...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess

🧠💊 What if product info for medicines wasn’t just a PDF, but a smart, digital platform?

In this article for #MedicalWriting, Open Pharma Co-founder Chris Winchester and co-authors explore how #ePI could transform how we access and understand medical data.

doi.org/10.56012/tcv...

Weekly digest: understanding research integrity, reaching the reader and achieving open access This week, we highlight a new study from STM designed to understand how publishers safeguard publishing integrity and signpost the call for submissions to the 2026 Researcher to Reader Conference. We ...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess

Weekly digest: ditch prompts, improve registries and explore Open Pharma This week, we listen to Conor Grennan as he explains why we should all ditch our trusty AI prompt libraries and just talk to AI like a person instead. We read the latest Open Pharma quarterly update a...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess

Open Pharma quarterly update: April–June 2025 Open Pharma quarterly update: April–June 2025. Read about what we've been up to this quarter!

Q2 2025 was a whirlwind at Open Pharma! 🚀

We launched two research projects, hit the conference circuit and welcomed a new Supporter.

Here’s what we’ve been up to 👇
www.openpharma.blog/blog/news/qu...

#OpenAccess #MedComms #OpenScience

Weekly digest: sustainable development, meaningful accessibility and AI in medicine This week, we signpost STM’s roadmap for implementing the UN’s 17 Sustainable Development Goals in academic publishing. We read about what meaningful accessibility means in academic publishing, and we...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #SDGs #Accessibility #AcademicPublishing #MedicalAI #TOPGuidelines #DiamondOA

🚨 Deadline extended! 🚨

#HCPs now have until 18 July to complete our survey on #OpenAccess in #MedicalResearch.

It’s quick (10 mins), and your input could help improve how research reaches clinicians like you.

🔗 Take the survey now: forms.office.com/pages/respon...

Weekly digest: AI interoperability standards, publishing misconduct and open peer review This week, we signpost an opportunity to contribute to NISO AI interoperability standards, feature a webinar about AI author tools at Springer Nature and include a reminder to register for the HIMSS A...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #ArtificialIntelligence #ScholarlyPublishing @nisoinfo.bsky.social @springernature.com ‬@nature.com

Weekly digest: equitable OA, AI survey and Elsa at the FDA This week, we encourage you to contribute to two surveys about open access and AI tools in research communication. We learn about Elsa – the new AI tool developed by the US FDA – and read our latest b...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #EquitableOA @oaspa.bsky.social #ResearchCommunication #AI @ALPSP.bsly.social #PeerReviewWeek

Weekly digest: Metascience 2025, ISMPP Annual and open science policy This week, we look ahead to a series of 10 virtual symposia taking place in the weeks leading up to Metascience 2025 and reflect on the 2025 Annual Meeting of ISMPP. We also read about how research fu...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess

Weekly digest: future of OA, author identities and retracted publications This week, we signpost a survey seeking input on the future of open access publishing and a webinar on how efforts to improve researcher identification could help combat research misconduct. We read a...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#OpenAccess #JournalImpactFactor #ImpactFactor #ResearchIntegrity

www.openpharma.blog/blog/transpa...

Weekly digest: AI-written papers, a PubMed alternative and retracted research This week, we welcome Alfasigma to Open Pharma and highlight 10 must-reads for transparent and reproducible pharmacoepidemiology research. We read about Springer Nature’s donation of a tool to spot AI...

📢 Read this week’s #OpenScience news here! 📢

Sign up to our blog to receive your weekly news digest and more straight to your inbox!

#ArtificalIntelligence #AI #PubMed #PredatoryPublishers #OpenAccess

www.openpharma.blog/blog/transpa...

Essential reading on transparency and reproducibility in pharmacoepidemiology research We all recognize that, without transparency, trust in research evidence can falter. Most of us, therefore, feel a responsibility to increase the transparency and reproducibility of our work. However, ...

🌟 Boosting transparency and reproducibility in RWE🌟

Dive into @antonpottegaard.bsky.social's essential reading for #PublicationProfessionals who want to contribute to a more robust and trustworthy research base ⤵️
www.openpharma.blog/blog/guest-p...

Alfasigma becomes a Member of Open Pharma Open Pharma is proud to announce that Alfasigma has become the latest Member of Open Pharma.

🎉 Alfasigma becomes the newest Member of Open Pharma!

Read the full press release on our blog ⤵️
#OpenPharma #OpenScience #PharmaceuticalsWithPassion #Welcome #Pharma
www.openpharma.blog/blog/news/al...